Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Rises By 115.9%

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) was the target of a significant growth in short interest in August. As of August 31st, there was short interest totaling 4,470,000 shares, a growth of 115.9% from the August 15th total of 2,070,000 shares. Approximately 10.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is presently 4.3 days. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is presently 4.3 days. Approximately 10.0% of the shares of the stock are sold short.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $8.44 on Friday. The stock’s fifty day moving average price is $5.94 and its two-hundred day moving average price is $5.32. The company has a market cap of $1.76 billion, a PE ratio of 105.50 and a beta of 2.04. Aveanna Healthcare has a fifty-two week low of $3.67 and a fifty-two week high of $8.54.

Analyst Ratings Changes

AVAH has been the topic of a number of analyst reports. Jefferies Financial Group raised Aveanna Healthcare from a “hold” rating to a “buy” rating and reduced their price target for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. UBS Group raised Aveanna Healthcare from a “sell” rating to a “neutral” rating and increased their price target for the stock from $6.75 to $8.00 in a research report on Tuesday, August 19th. Barclays raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. Raymond James Financial raised Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 price target on the stock in a research report on Monday, August 11th. Finally, Truist Financial reduced their price target on Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research report on Wednesday, July 16th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $7.50.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently modified their holdings of the business. Squarepoint Ops LLC boosted its holdings in shares of Aveanna Healthcare by 207.0% during the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock valued at $2,510,000 after acquiring an additional 323,656 shares in the last quarter. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $64,000. Lazard Asset Management LLC acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $791,000. BNP Paribas Financial Markets boosted its holdings in shares of Aveanna Healthcare by 1,208.6% during the 2nd quarter. BNP Paribas Financial Markets now owns 47,215 shares of the company’s stock valued at $247,000 after acquiring an additional 43,607 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of Aveanna Healthcare by 172.0% during the 2nd quarter. Bank of America Corp DE now owns 143,405 shares of the company’s stock valued at $750,000 after acquiring an additional 90,673 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.